Nix | Jotup

Five LBMC Leaders Named 2024 Nashville Post In Charge

Retrieved on:

화요일, 5월 7, 2024

Nix, Management consulting, Burnette, Management, Assets under management, Growth, PC, NashvillePost.com, LBMC, Partner

Nashville, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- LBMC , a top accounting and business consulting firm in the nation, is pleased to announce that five of its top executives have been named to the Nashville Post In Charge list for 2024.

Key Points:

Nashville, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- LBMC , a top accounting and business consulting firm in the nation, is pleased to announce that five of its top executives have been named to the Nashville Post In Charge list for 2024.
Four of the firm’s executives were recognized in the Nashville Post In Charge Finance category, and one leader was named to the Management Consulting list.
Paul Demastus is Chairman of the Board of LBMC, PC and an Audit Shareholder with more than 30 years of experience.
“We are honored to be named to the Nashville Post In Charge list, a tribute to leaders from across LBMC's various sectors.

Diabetes Canada awards over $6 million in funding to new research projects

Retrieved on:

월요일, 1월 22, 2024

Diabetes, Health, B cell, Research, Diabetes Canada, Daisy Syron Russell, Risk, Leg, Type 2 diabetes, Nix, Caregiver, Insulin resistance, Prediabetes, Pharmaceutical industry

Each research project receives a $100,000 grant annually for three years for a total of $6.2 million in funds committed by Diabetes Canada for the research community.

Key Points:

Each research project receives a $100,000 grant annually for three years for a total of $6.2 million in funds committed by Diabetes Canada for the research community.
“To achieve our vision of a world free of the effects of diabetes, Diabetes Canada knows that it needs to harness the transformative and combined power of technological, medical, and scientific research,” says Laura Syron, President and CEO of Diabetes Canada.
The winning research projects for this year’s Diabetes Canada’s End Diabetes Awards were rigorously evaluated by scientists with expertise in diabetes research, with input from people with lived experience, and Diabetes Canada’s National Research Council.
For almost 50 years, Diabetes Canada has proudly supported outstanding diabetes research in Canada, administering more than $160 million in research grants, awards and partnerships to scientists and clinicians who have dedicated their careers to the fight against diabetes.

Vetsource showcases expansion to its payment services at VMX veterinary conference

Retrieved on:

수요일, 1월 10, 2024

Research, VMX, Health, Pharmacy, Payment, Nix, PIMS, KPI, Online shopping

PORTLAND, Ore., Jan. 10, 2024 /PRNewswire/ -- Vetsource's Payment Services will be on display at VMX 2024, demonstrating to attendees how it provides a faster, more efficient checkout process and simple end-of-day reconciliation. Designed specifically for veterinary practices, this is one of several services that Vetsource®, a leader in pet pharmacy and technology services, will be exhibiting at VMX in Orlando, Fla., Jan. 13-17, 2024.

Key Points:

Vetsource kicks off the new year by highlighting standalone payment services solution, a new digital scripting experience, an expanded pharmacy dashboard and data services at booth #1377.
Designed specifically for veterinary practices, this is one of several services that Vetsource® , a leader in pet pharmacy and technology services, will be exhibiting at VMX in Orlando, Fla., Jan. 13-17, 2024.
"The onboarding/support process [for Payment Services] has been easy and streamlined," said Lee Ann Nix, a veterinary practice COO.
It features an easy-to-use interface with simple payment processing, flexible payment options and dedicated support from veterinary industry experts.

Anchore Reports Strong Success in Federal and Enterprise Markets, Team Growth

Retrieved on:

화요일, 11월 14, 2023

SANTA BARBARA, Calif., Nov. 14, 2023 /PRNewswire/ -- Anchore, Inc., the leading experts in software supply chain security and federal compliance, today announced strong growth and continued business momentum heading into 2024.

Key Points:

"Despite the broader economic hurdles, we're ecstatic to see continued growth in demand for Anchore's security solutions," remarked Saïd Ziouani, Anchore CEO.
In preparation for continued growth and advancement in 2024, Anchore added two new industry leaders to its advisory team.
As the company continues to advance and expand, Anchore has added two enterprise software industry veterans to its management team.
Anchore Enterprise 5.0 now includes integrations with ServiceNow and Harness which complement its support for existing platforms such as GitLab, GitHub, and Jenkins.

Learn, Connect, Grow & Celebrate at the Comerica Bank Women's Business Symposium April 13

Retrieved on:

월요일, 3월 27, 2023

Girls, Inc., Balboa Bay Resort, Comerica, Woman, Celebrate, Paye, KTLA, Nix, Master of ceremonies, Radio, Lakers–Clippers rivalry, Unite, News, Management, Los Angeles Lakers

DALLAS, March 27, 2023 /PRNewswire/ -- The Comerica Bank Women's Business Symposium returns to Southern California, helping women in business Learn, Connect, Grow & Celebrate their potential.

Key Points:

DALLAS, March 27, 2023 /PRNewswire/ -- The Comerica Bank Women's Business Symposium returns to Southern California, helping women in business Learn, Connect, Grow & Celebrate their potential.
Entering its 17th year, the Comerica Bank Women's Business Symposium brings together women business owners, executives and professionals at all levels from across Southern California to "Power Up Your Potential" through inspiring speakers, connecting them with business leaders and discovering opportunities to help them grow personally and professionally.
Emceeing the Comerica Bank Women's Business Symposium is celebrity chef, syndicated radio host and cookbook author Jamie Gwen.
The Comerica Bank Women's Business Symposium is proud to provide women business owners, executives, and professionals the opportunity to Learn, Connect, Grow & Celebrate.

Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound

Retrieved on:

수요일, 2월 15, 2023

LA JOLLA, Calif. and CAMBRIDGE, Mass., Feb. 15, 2023 /PRNewswire/ -- Calibr, a division of Scripps Research dedicated to the "bench to bedside" development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute (Gates MRI), today announced a strategic licensing agreement to advance development of a novel investigational compound for tuberculosis treatment. Under the agreement, Calibr is granting Gates MRI an exclusive license to continue the development of the investigational compound CLB073 for tuberculosis treatment. Calibr will transition CLB073 to Gates MRI for further development.

Key Points:

LA JOLLA, Calif. and CAMBRIDGE, Mass., Feb. 15, 2023 /PRNewswire/ -- Calibr, a division of Scripps Research dedicated to the "bench to bedside" development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute (Gates MRI), today announced a strategic licensing agreement to advance development of a novel investigational compound for tuberculosis treatment.
Under the agreement, Calibr is granting Gates MRI an exclusive license to continue the development of the investigational compound CLB073 for tuberculosis treatment.
"At Calibr, we have been working with collaborators, through the support of the Bill & Melinda Gates Foundation, to discover and develop novel medicines for diseases that require improved treatment regimens, such as tuberculosis.
"Tuberculosis is one of the world's most significant infectious causes of human disease and death," said Emilio Emini, PhD, chief executive officer of the Bill & Melinda Gates Medical Research Institute.

Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound

Retrieved on:

수요일, 2월 15, 2023

LA JOLLA, Calif. and CAMBRIDGE, Mass., Feb. 15, 2023 /PRNewswire/ -- Calibr, a division of Scripps Research dedicated to the "bench to bedside" development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute (Gates MRI), today announced a strategic licensing agreement to advance development of a novel investigational compound for tuberculosis treatment. Under the agreement, Calibr is granting Gates MRI an exclusive license to continue the development of the investigational compound CLB073 for tuberculosis treatment. Calibr will transition CLB073 to Gates MRI for further development.

Key Points:

LA JOLLA, Calif. and CAMBRIDGE, Mass., Feb. 15, 2023 /PRNewswire/ -- Calibr, a division of Scripps Research dedicated to the "bench to bedside" development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute (Gates MRI), today announced a strategic licensing agreement to advance development of a novel investigational compound for tuberculosis treatment.
Under the agreement, Calibr is granting Gates MRI an exclusive license to continue the development of the investigational compound CLB073 for tuberculosis treatment.
"At Calibr, we have been working with collaborators, through the support of the Bill & Melinda Gates Foundation, to discover and develop novel medicines for diseases that require improved treatment regimens, such as tuberculosis.
"Tuberculosis is one of the world's most significant infectious causes of human disease and death," said Emilio Emini, PhD, chief executive officer of the Bill & Melinda Gates Medical Research Institute.

flox Raises $27 Million, Introduces Open Source Platform to Bring Nix to Everyone

Retrieved on:

화요일, 2월 7, 2023

NEW YORK, Feb. 7, 2023 /PRNewswire/ -- flox, the company bringing the power of Nix to everyone, today announced it has raised $16.5 million in its Series A led by New Enterprise Associates (NEA), bringing total funding to date to $27 million. flox was incubated at DESCOvery, the D. E. Shaw group's venture studio, and its early backers include Addition and Hetz Ventures. Notable angel investors include Thomas Dohmke, CEO at Github; Guy Podjarny, founder of Snyk; and James Turnbull, former CTO at Microsoft for Startups and VP at Docker, currently CTO at Sotheby's.

Key Points:

The company today is also introducing its new open source flox platform and is expected to release its enterprise platform later this year.
By creating an easy-to-use platform around Nix, flox supercharges productivity for developers everywhere while also making their software more secure."
"We're excited to partner with Ron and his talented team as they continue to expand and roll out their new open source platform to bring Nix to everyone."
"The platform is still used at the D. E. Shaw group today, and we're excited about the value that we believe flox can bring to developers everywhere."

Nix Launches First Biosensor to Provide Real-Time Sweat Science to Athletes

Retrieved on:

수요일, 12월 7, 2022

BOSTON, Dec. 7, 2022 /PRNewswire/ -- Nix, the biosensor company delivering health and wellness data to consumers, launches the Nix Hydration Biosensor today. It is the first-ever consumer biosensor to analyze sweat and provide endurance athletes with personalized hydration data — scientifically validated and delivered in real-time.

Key Points:

BOSTON, Dec. 7, 2022 /PRNewswire/ -- Nix , the biosensor company delivering health and wellness data to consumers, launches the Nix Hydration Biosensor today.
It is the first-ever consumer biosensor to analyze sweat and provide endurance athletes with personalized hydration data scientifically validated and delivered in real-time.
With hydration intelligence, athletes no longer need to leave proper hydration to chance and can make informed decisions based on their unique sweat profile.
The Nix Hydration Biosensor is now available for purchase at nixbiosensors.com for $129 and comes with one Pod, four Sweat Patches, one Charging Case, and one USB cable.

Puig pleads not guilty in federal case

Retrieved on:

수요일, 11월 30, 2022

Athlete, Gambling, Rodney, Nix, Interview, LAPD, Corruption, Government, Cryptocurrency, Sport

LOS ANGELES, Nov. 30, 2022 /PRNewswire/ -- Attorneys for Yasiel Puig announced today that significant new evidence has prompted Puig to withdraw his agreement to plead guilty to a charge of lying to federal investigators and change his plea to not guilty.

Key Points:

LOS ANGELES, Nov. 30, 2022 /PRNewswire/ -- Attorneys for Yasiel Puig announced today that significant new evidence has prompted Puig to withdraw his agreement to plead guilty to a charge of lying to federal investigators and change his plea to not guilty.
In mid-November, Puig reached an agreement to plead guilty to one count of making false statements to federal investigators probing an illegal gambling ring in Southern California.
Four other men also pled guilty to federal charges in the Nix case.
Middleton was one of four attorneys who prosecuted the federal civil rights trial of LAPD officers in the Rodney King case.